Real-time enrollment status for this diabetic macular edema clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:52 PM UTC
| NCT Number | NCT06536491 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Macular Edema |
| Phase | PHASE1 |
| Target Enrollment | 75 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Eclipse Life Sciences, Inc. |
| Last Updated on CT.gov | January 22, 2025 (Jan 22, 2025) |
As of July 18, 2026: Clinical trial NCT06536491 is currently recruiting participants. This phase1 study for diabetic macular edema is actively seeking new participants at 1 location across the United States. The study is sponsored by Eclipse Life Sciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06536491 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06536491 was last updated Jan 22, 2025 (January 22, 2025). HelloStudys verifies this status automatically.